Research Article
gp91phox, a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism
Table 1
Clinical characteristics of four groups in the study.
| | Healthy controls | Controls with high LDL | SH with normal LDL | SH with high LDL | | | n = 13 | n = 12 | n = 11 | n = 15 |
| Gender (F/M) | 10/3 | 9/3 | 9/2 | 11/3 | 0.978 | - | Age (years) | 50.38 ± 3.52 | 50.33 ± 4.12 | 54.09 ± 6.88 | 51.60 ± 7.60 | 0.202 | 0.423 | BMI (kg/m2) | 22.9 ± 2.21 | 23.15 ± 2.48 | 24.48 ± 2.62 | 24.44 ± 2.31 | 0.343 | 0.172 | TC (mmol/L) | 4.56 ± 0.37 | 5.41 ± 0.39 | 5.54 ± 0.53 | 6.31 ± 1.00 | <0.001 | <0.001 | LDL-C (mmol/L) | 2.27 ± 0.53 | 3.65 ± 0.30 | 2.86 ± 0.28 | 4.02 ± 0.61 | N/A | N/A | HDL-C (mmol/L) | 1.35 ± 0.13 | 1.19 ± 0.13 | 1.18 ± 0.16 | 1.45 ± 0.34 | 0.021 | 0.782 | TG (mmol/L) | 1.05 ± 0.34 | 1.16 ± 0.36 | 1.15 ± 0.34 | 1.40 ± 0.34 | 0.144 | 0.020 | FBG (mmol/L) | 5.08 ± 0.41 | 4.97 ± 0.65 | 5.50 ± 0.73 | 6.58 ± 2.18 | 0.008 | 0.169 | FT3 (pmol/L) | 5.20 ± 0.62 | 5.47 ± 0.36 | 4.93 ± 0.71 | 4.73 ± 0.28 | 0.002 | 0.028 | FT4 (pmol/L) | 16.41 ± 1.58 | 17.76 ± 1.65 | 15.36 ± 1.85 | 15.59 ± 2.04 | 0.013 | 0.397 | TSH (mIU/L) | 2.22 ± 0.92 | 2.19 ± 0.85 | 6.62 ± 1.98 | 7.17 ± 2.58 | N/A | N/A |
|
|
, nonparametric one-way Kruskal–Wallis for all the four groups; , healthy controls vs. SH with high LDL. BMI : body mass index; TC : total cholesterol; LDL-C : low-density lipoprotein cholesterol; HDL-C : high-density lipoprotein cholesterol; TG : triglyceride; FBG : fasting blood glucose; FT3 : free triiodothyronine; FT4 : free thyroxine; TSH: thyroid stimulating hormone. |